| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-30-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| | 10-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Industrial Injury Prevention Services Revenues | 77.1 | 43.9 | | 39.2 | 37.5 | 25.5 | | |
| Physical Therapy Operations | 476.1 | 451.1 | | 383.8 | 444.5 | 428.4 | | |
| Total revenues | 553.1 | 495.0 | | 423.0 | 482.0 | 453.9 | 414.1 | 280.5 |
| Revenue growth [+] | 11.7% | 17.0% | | -12.2% | 6.2% | 9.6% | 47.6% | -15.3% |
| Industrial Injury Prevention Services Revenues | 75.5% | 12.0% | | 4.6% | 47.1% | | | |
| Physical Therapy Operations | 5.5% | 17.6% | | -13.7% | 3.7% | | | |
| Cost of goods sold | 319.2 | 278.5 | | 235.6 | 274.2 | 259.2 | 237.1 | 198.5 |
| Gross profit | 234.0 | 216.6 | | 187.3 | 207.7 | 194.7 | 177.0 | 82.0 |
| Gross margin | 42.3% | 43.7% | | 44.3% | 43.1% | 42.9% | 42.7% | 29.2% |
| Selling, general and administrative | 46.1 | 46.5 | | 42.0 | 45.0 | 41.3 | 35.9 | 32.5 |
| Equity in earnings | 1.2 | 0.1 | | | | | | |
| Other operating expenses | 121.9 | 99.4 | | 92.9 | 95.2 | 93.0 | 85.8 | -0.1 |
| EBITDA [+] | 81.8 | 82.4 | | 62.9 | 77.5 | 70.1 | 65.0 | 58.4 |
| EBITDA growth | -0.6% | 30.8% | | -18.8% | 10.7% | 7.7% | 11.3% | 5.4% |
| EBITDA margin | 14.8% | 16.6% | | 14.9% | 16.1% | 15.4% | 15.7% | 20.8% |
| Depreciation | 8.2 | 7.9 | | 7.1 | 7.1 | 7.0 | 7.1 | 6.4 |
| EBITA | 73.6 | 74.5 | | 55.8 | 70.5 | 63.1 | 58.0 | 52.0 |
| EBITA margin | 13.3% | 15.0% | | 13.2% | 14.6% | 13.9% | 14.0% | 18.5% |
| Amortization of intangibles | 6.5 | 3.7 | | 3.4 | 3.0 | 2.8 | 2.7 | 2.4 |
| EBIT [+] | 67.1 | 70.8 | | 52.4 | 67.5 | 60.3 | 55.3 | 49.7 |
| EBIT growth | -5.2% | 35.0% | | -22.3% | 11.8% | 9.0% | 11.4% | 4.5% |
| EBIT margin | 12.1% | 14.3% | | 12.4% | 14.0% | 13.3% | 13.4% | 17.7% |
| Non-recurring items [+] | 9.1 | | | | 0.0 | 0.0 | 0.6 | 0.1 |
| Asset impairment | 9.1 | | | | | | | |
| Interest expense, net [+] | -0.9 | -0.2 | | -0.1 | 0.0 | -0.1 | 21.1 | 11.5 |
| Interest expense | | | | | | | 21.1 | 11.5 |
| Interest income | 0.9 | 0.2 | | 0.1 | 0.0 | 0.1 | | |
| Other income (expense), net [+] | -3.3 | 2.2 | | 13.0 | 3.4 | -0.2 | 0.1 | 0.1 |
| Gain (loss) on investments | | | | 1.1 | 5.5 | | | |
| Litigation settlement | | -2.6 | | | | | | |
| Gain (loss) on debt retirement | | | | | | 1.8 | | |
| Pre-tax income | 55.6 | 73.2 | | 65.5 | 70.9 | 60.2 | 33.8 | 38.1 |
| Income taxes | 12.2 | 15.3 | | 13.0 | 13.6 | 11.4 | 6.0 | 11.9 |
| Tax rate | 21.9% | 20.9% | | 19.9% | 19.2% | 18.9% | 17.9% | 31.1% |
| Minority interest | 11.2 | 17.1 | | 17.3 | 17.2 | 14.0 | 5.5 | 5.7 |
| Net income | 32.2 | 40.8 | | 35.2 | 40.0 | 34.9 | 22.3 | 20.6 |
| Net margin | 5.8% | 8.2% | | 8.3% | 8.3% | 7.7% | 5.4% | 7.3% |
| |
| Basic EPS [+] | $2.48 | $3.17 | | $2.74 | $3.14 | $2.75 | $1.77 | $1.64 |
| Growth | -21.8% | 15.5% | | -12.6% | 14.0% | 55.5% | 7.7% | -1.2% |
| Diluted EPS [+] | $2.48 | $3.17 | | $2.74 | $3.14 | $2.75 | $1.77 | $1.64 |
| Growth | -21.8% | 15.5% | | -12.6% | 14.0% | 55.5% | 7.7% | -1.2% |
| |
| Dividends per share [+] | $1.64 | $1.46 | | $0.32 | $1.14 | $0.92 | $0.80 | $0.68 |
| Growth | 12.3% | 356.3% | | -71.9% | 23.9% | 15.0% | 17.6% | 13.3% |
| |
| Shares outstanding (basic) [+] | 13.0 | 12.9 | | 12.8 | 12.8 | 12.7 | 12.6 | 12.5 |
| Growth | 0.7% | 0.5% | | 0.6% | 0.7% | 0.8% | 0.6% | 0.9% |
| Shares outstanding (diluted) [+] | 13.0 | 12.9 | | 12.8 | 12.8 | 12.7 | 12.6 | 12.5 |
| Growth | 0.7% | 0.5% | | 0.6% | 0.7% | 0.8% | 0.6% | 0.9% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |